Controlled-release formulations of interleukin-2
AssigneeCetus Corporation
InventorsManinder Singh, Jack H. Nunberg, Thomas R. Tice, Michael E. Hudson, Richard M. Gilley, Terrance A. Taforo
Life of this patent
Estimating the term…
Loading patent…
AssigneeCetus Corporation
InventorsManinder Singh, Jack H. Nunberg, Thomas R. Tice, Michael E. Hudson, Richard M. Gilley, Terrance A. Taforo
Estimating the term…
Shipping fever, and other stress-related diseases in livestock, are treated by administration of a microencapsulated composition comprising IL-2 conjugated with a polyoxyethylene polymer, and mixed with a release-modulating amount of humen serum albumin. The microcapsules are administered parenterally, and release an effective amount of conjugated IL-2 continuously over a period of 14-30 days. These microcapsules are also effective in the treatment of cancer in mammals.
A composition for continuously delivering a relatively constant, effective amount of PEGyl-IL-2 comprising:
A formulation for administering IL-2 or an IL-2 equivalent continuously over a period of 14-30 days, which formulation comprises:
Dependencies are inferred from the claim text.